JBT MAREL Corp (JBTM) Form 10-Q — Nov 3, 2026

$JBTMForm 10-QFiled Nov 3, 2026, 5:03 PM ET0001628280-26-069624Original filing

JBT Marel Corp (NYSE: JBTM) reported Q3 2026 net income of $70M ($1.35 basic EPS) on revenue of $994M, with Adjusted EBITDA margin expanding 90 bps to 18.0%. For the nine months, revenue grew 4.3% to $2,911M with a swing from a $104M loss to $143M in net income. The Board authorized a $500 million increase to the share repurchase program on October 30, 2026, bringing total authorization to $700 million through May 2029. The company repurchased 800,855 shares at an average of $117.59 in August 2026.

Key figures

Eps: $1.35 basic / $1.34 diluted (Q3); $2.74 basic / $2.73 diluted (9M)
Revenue: $994M (Q3 2026); $2,911M (9M 2026)
Net Income: $70M (Q3 2026); $143M (9M 2026)
Total Debt: $1,719M gross outstanding debt
Revenue Yoy: -0.7% Q3; +4.3% nine months
Cash Position: $98M (Sept 30, 2026)
Total assets: $7,969M
Buyback increase: $500M increase to $700M total authorization
Free cash flow 9m: $252M
Adjusted ebitda 9m: $489M (16.8% margin, +110 bps)
Adjusted ebitda q3: $179M (18.0% margin, +90 bps)
Operating cash flow 9m: $320M
Adjusted diluted eps 9m: $5.73 vs $4.42 prior year
Adjusted diluted eps q3: $2.19 vs $1.94 prior year
Total stockholders equity: $4,429M
Prepared food bev revenue 9m: $1,515M (-2.3%)
Protein solutions revenue 9m: $1,396M (+12.6%)
Remaining performance obligations: $1.5B

AI analysis

Red flags4 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

Upgrade to Pro · $49/mo billed annually

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.